Stroke research priorities for the next decade--A representative view of the European scientific community.
Meairs
Stephen
S
Neurologische Klinik, Ruprecht-Karls-Universitat Heidelberg, Theodor-Kutzer-Ufer, DE-68135 Mannheim (Germany). meairs@neuro.ma.uni-heidelberg.de
Wahlgren
Nils
N
Dirnagl
Ulrich
U
Lindvall
Olle
O
Rothwell
Peter
P
Baron
Jean-Claude
JC
Hossmann
Konstantin
K
Engelhardt
Britta
B
Ferro
José
J
McCulloch
James
J
Kaste
Markku
M
Endres
Matthias
M
Koistinaho
Jari
J
Planas
Anna
A
Vivien
Denis
D
Dijkhuizen
Rick
R
Czlonkowska
Anna
A
Hagen
Arne
A
Evans
Alan
A
De Libero
Gennaro
G
Nagy
Zoltan
Z
Rastenyte
Daiva
D
Reess
Jürgen
J
Davalos
Antoni
A
Lenzi
Gian Luigi
GL
Amarenco
Pierre
P
Hennerici
Michael
M
D000818:Animals; D002545:Brain Ischemia / Q000188:drug therapy* / Q000517:prevention & control / Q000628:therapy; D002560:Cerebrovascular Circulation / Q000187:drug effects; D003299:Cooperative Behavior; D004195:Disease Models, Animal; D005060:Europe; D005343:Fibrinolytic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D033183:Interdisciplinary Communication; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D012106:Research / Q000639:trends*; D055502:Secondary Prevention; D033581:Stem Cell Transplantation / Q000379:methods; D020521:Stroke / Q000188:drug therapy* / Q000517:prevention & control / Q000628:therapy; D013997:Time Factors; D010959:Tissue Plasminogen Activator / Q000494:pharmacology / Q000627:therapeutic use*
D005343:Fibrinolytic Agents; D018696:Neuroprotective Agents; D010959:Tissue Plasminogen Activator